hI Werds,
the current short term FDA opportunity is worth circa NZD$25- 27 million in sales (1 million tins) and $5-6 million in profit( less any extra over overheads). Not a game changer by any means.
the big kicker is if FDA grants permanent access and A2 would be able to sell IF ongoing, you could see this growing to 5 million tins a year business i.e NZD$125-150 million sales and $25-30 million in profit.
hI Werds,the current short term FDA opportunity is worth circa...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.17 |
Change
-0.060(0.96%) |
Mkt cap ! $4.460B | |||
| Open | High | Low | Value | Volume |
| $6.20 | $6.24 | $6.17 | $5.737M | 926.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12415 | $6.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.18 | 24019 | 2 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.20 |
Change
-0.060 ( 0.67 %) |
||||
| Open | High | Low | Volume | ||
| $6.20 | $6.24 | $6.18 | 298014 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| A2M (ASX) Chart |